Analytical chemists explain how sample prep can create or hide impurities in GLP-1 drugs, and why methionine oxidation hurts reproducibility.
Recap by typeshit. Full story at LCGC International.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
Women's Health asks researchers what people should know about a more potent GLP-1 medication that is still being tested in trials.
Pink Sheet editors say FDA reviewers warn the peptides lack clinical testing, and some career staff may quit if the order goes ahead.
Loading…